s'inscrire
Conseils d'fr.eurobuch.ch
Livres similaires
Autres livres qui pourraient ressembler au livre recherché:
Outils de recherche
Livre conseillé
Actualités
Publicité
Annonce payée
- 0 Résultats
prix le plus bas: € 34,15, prix le plus élevé: € 44,99, prix moyen: € 40,58
Progress in Neurotherapeutics and Neuropsychopharmacology: Volume 3, 2008 - Cummings, Jeffrey L. (ed.)
Livre non disponible
(*)
Cummings, Jeffrey L. (ed.):
Progress in Neurotherapeutics and Neuropsychopharmacology: Volume 3, 2008 - Livres de poche

2008, ISBN: 9780521115612

[ED: Taschenbuch], [PU: CAMBRIDGE UNIV PR], An essential update of recent clinical trials in the management of neurological and neuropsychiatric disorders. Published annually, volumes in this series provide readers with updates of recent clinical trial results, impacts of trials on guidelines and evidence-based practice, advances in trial methodologies, and the evolution of biomarkers in trials. The series focuses on trials in neurotherapeutics, including disease-modifying and symptomatic agents for neurological diseases, psychopharmacological management of neurologic and psychiatric illnesses, and non-drug treatments. Each paper is authored by a leader in the area of neurotherapeutics and clinical trials, and the series is guided by an editor-in-chief and editorial board with broad experience in drug development and neuropsychopharmacology. Progress in Neurotherapeutics and Neuropsychopharmacology is an essential update of recent trials in all aspects of the management of neurologic and neuropsychiatric disorders, and will be an invaluable resource for practising neurologists as well as clinical and translational neuroscientists. Table of contents: Contributors 1. Progress in neurotherapeutics and neuropsychopharmacology Jeffrey L. Cummings 2. Trifusal versus aspirin for the prevention of stroke Antonio Culebras, Javier Borja and Julián García-Rafanell 3. The Argatroban and tPA stroke study Andrew D. Barreto and James C. Grotta 4. Use of Selegiline as monotherapy and in combination with Levodopa in the management of Parkinson's disease: perspectives from the MONOCOMB study Sven E. Pålhagen and Esa Heinonen 5. Ropinirole 24-h prolonged release in advanced Parkinson's disease: review of a randomised, double-blind, placebo-controlled study (EASE PD - adjunct study) Kelly E. Lyons and Rajesh Pahwa 6. Insulin resistance and Alzheimer's disease: pathophysiology and treatment G. Stennis Watson and Suzanne Craft 7. Targeting Amyloid with Tramiprosate in patients with mild-to-moderate Alzheimer's disease P. S. Aisen, R. Briand, D. Saumier, J. Laurin, A. Duong and D. Garceau 8. Intranasal Zolmitriptan is effective and well-tolerated in acute cluster headache: a randomized placebo-controlled double-blind crossover study E. Cittadini and P. J. Goadsby 9. Optimal dosing of immunomodulating drugs: a dose-comparison study of GA in RRMS Daniel Wynn, Catherine Meyer, Neil Allen and Dennis O'Brien 10. Tetrathiomolybdate versus Trientine in the initial treatment of neurologic Wilson's disease George J. Brewer, Fred Askari, Matthew T. Lorincz, Martha Carlson, Michael Schilsky, Karen J. Kluin, Peter Hedera, Paolo Moretti, John K. Fink, Roberta Tankanow, Robert B. Dick and Julia Sitterly 11. Randomized clinical trials of Pregabalin for neuropathic pain: methods, results, and implications Robert H. Dworkin, Rajbala Thakur, Teresa Griesing, Uma Sharma and James P. Young 12. Effect of Methylphenidate in patients with acute traumatic brain injury: a randomized clinical trial Hossein A. Khalili and Kamyar Keramatian 13. Improvement in speeded cognitive processing after anti-epileptic drug withdrawal - a controlled study in mono-therapy patients Erik Hessen, Morten I. Lossius, Ivar Reinvang and Leif Gjerstad 14. A randomized-controlled trial of bilateral rTMS for treatment-resistant depression Paul B. Fitzgerald 15. Serotonin related genes affect antidepressant treatment in obsessive-compulsive disorder F. Van Nieuwerburgh, D. Deforce and D. A. J. P. Denys 16. Night eating syndrome and results from the first placebo-controlled trial of treatment, with the SSRI medication, Sertraline: implications for clinical practice John P. O'Reardon Karen E. Groff, Albert J. Stunkard and Kelly C. Allison 17. Modafinil: a candidate for pharmacotherapy of negative symptoms in schizophrenia John H. Peloian and Joseph M. Pierre 18. New approaches to treatment of schizophrenia by enhancing N-methyl-D-aspartate neurotransmission Guochuan Emil Tsai Subject index Author index. ca. 312 p. - 244 x 170 mm - 500 g Versandfertig in 2-4 Wochen, DE, [SC: 0.00], Neuware, gewerbliches Angebot, offene Rechnung (Vorkasse vorbehalten)

Nouveaux livres Booklooker.de
buecher.de GmbH & Co. KG
Frais d'envoiVersandkostenfrei, Versand nach Deutschland. (EUR 0.00)
Details...
(*) Livre non disponible signifie que le livre est actuellement pas disponible à l'une des plates-formes associées nous recherche.
Progress in Neurotherapeutics and Neuropsychopharmacology: Volume 3, 2008 - Cummings, Jeffrey L. (ed.)
Livre non disponible
(*)
Cummings, Jeffrey L. (ed.):
Progress in Neurotherapeutics and Neuropsychopharmacology: Volume 3, 2008 - Livres de poche

2008, ISBN: 9780521115612

[ED: Taschenbuch], [PU: CAMBRIDGE UNIV PR], An essential update of recent clinical trials in the management of neurological and neuropsychiatric disorders. Published annually, volumes in this series provide readers with updates of recent clinical trial results, impacts of trials on guidelines and evidence-based practice, advances in trial methodologies, and the evolution of biomarkers in trials. The series focuses on trials in neurotherapeutics, including disease-modifying and symptomatic agents for neurological diseases, psychopharmacological management of neurologic and psychiatric illnesses, and non-drug treatments. Each paper is authored by a leader in the area of neurotherapeutics and clinical trials, and the series is guided by an editor-in-chief and editorial board with broad experience in drug development and neuropsychopharmacology. Progress in Neurotherapeutics and Neuropsychopharmacology is an essential update of recent trials in all aspects of the management of neurologic and neuropsychiatric disorders, and will be an invaluable resource for practising neurologists as well as clinical and translational neuroscientists. Table of contents: Contributors 1. Progress in neurotherapeutics and neuropsychopharmacology Jeffrey L. Cummings 2. Trifusal versus aspirin for the prevention of stroke Antonio Culebras, Javier Borja and Julián García-Rafanell 3. The Argatroban and tPA stroke study Andrew D. Barreto and James C. Grotta 4. Use of Selegiline as monotherapy and in combination with Levodopa in the management of Parkinson's disease: perspectives from the MONOCOMB study Sven E. Pålhagen and Esa Heinonen 5. Ropinirole 24-h prolonged release in advanced Parkinson's disease: review of a randomised, double-blind, placebo-controlled study (EASE PD - adjunct study) Kelly E. Lyons and Rajesh Pahwa 6. Insulin resistance and Alzheimer's disease: pathophysiology and treatment G. Stennis Watson and Suzanne Craft 7. Targeting Amyloid with Tramiprosate in patients with mild-to-moderate Alzheimer's disease P. S. Aisen, R. Briand, D. Saumier, J. Laurin, A. Duong and D. Garceau 8. Intranasal Zolmitriptan is effective and well-tolerated in acute cluster headache: a randomized placebo-controlled double-blind crossover study E. Cittadini and P. J. Goadsby 9. Optimal dosing of immunomodulating drugs: a dose-comparison study of GA in RRMS Daniel Wynn, Catherine Meyer, Neil Allen and Dennis O'Brien 10. Tetrathiomolybdate versus Trientine in the initial treatment of neurologic Wilson's disease George J. Brewer, Fred Askari, Matthew T. Lorincz, Martha Carlson, Michael Schilsky, Karen J. Kluin, Peter Hedera, Paolo Moretti, John K. Fink, Roberta Tankanow, Robert B. Dick and Julia Sitterly 11. Randomized clinical trials of Pregabalin for neuropathic pain: methods, results, and implications Robert H. Dworkin, Rajbala Thakur, Teresa Griesing, Uma Sharma and James P. Young 12. Effect of Methylphenidate in patients with acute traumatic brain injury: a randomized clinical trial Hossein A. Khalili and Kamyar Keramatian 13. Improvement in speeded cognitive processing after anti-epileptic drug withdrawal - a controlled study in mono-therapy patients Erik Hessen, Morten I. Lossius, Ivar Reinvang and Leif Gjerstad 14. A randomized-controlled trial of bilateral rTMS for treatment-resistant depression Paul B. Fitzgerald 15. Serotonin related genes affect antidepressant treatment in obsessive-compulsive disorder F. Van Nieuwerburgh, D. Deforce and D. A. J. P. Denys 16. Night eating syndrome and results from the first placebo-controlled trial of treatment, with the SSRI medication, Sertraline: implications for clinical practice John P. O'Reardon Karen E. Groff, Albert J. Stunkard and Kelly C. Allison 17. Modafinil: a candidate for pharmacotherapy of negative symptoms in schizophrenia John H. Peloian and Joseph M. Pierre 18. New approaches to treatment of schizophrenia by enhancing N-methyl-D-aspartate neurotransmission Guochuan Emil Tsai Subject index Author index. ca. 312 p. - 244 x 170 mm - 500 g Versandfertig in 2-4 Wochen, DE, Neuware, gewerbliches Angebot, offene Rechnung (Vorkasse vorbehalten)

Nouveaux livres Booklooker.de
buecher.de GmbH & Co. KG
Frais d'envoizzgl. Versandkosten, Livraison non-comprise
Details...
(*) Livre non disponible signifie que le livre est actuellement pas disponible à l'une des plates-formes associées nous recherche.
Progress in Neurotherapeutics and Neuropsychopharmacology: Volume 3, 2008 - Jeffrey L. Cummings
Livre non disponible
(*)
Jeffrey L. Cummings:
Progress in Neurotherapeutics and Neuropsychopharmacology: Volume 3, 2008 - Livres de poche

2008, ISBN: 9780521115612

ID: 9780521115612

Progress in Neurotherapeutics and Neuropsychopharmacology: Volume 3, 2008 Progress-in-Neurotherapeutics-and-Neuropsychopharmacology~~Jeffrey-L-Cummings Psychology>Study of Psychology>Study of Psychology Paperback, Cambridge University Press

Nouveaux livres Barnesandnoble.com
new Frais d'envoizzgl. Versandkosten., Livraison non-comprise
Details...
(*) Livre non disponible signifie que le livre est actuellement pas disponible à l'une des plates-formes associées nous recherche.
Progress in Neurotherapeutics and Neuropsychopharmacology: Volume 3, 2008 - Jeffrey L. Cummings
Livre non disponible
(*)
Jeffrey L. Cummings:
Progress in Neurotherapeutics and Neuropsychopharmacology: Volume 3, 2008 - nouveau livre

2008, ISBN: 9780521115612

ID: 726998059

An essential update of recent clinical trials in the management of neurological and neuropsychiatric disorders. 200 Buch (fremdspr.) Bücher>Fremdsprachige Bücher>Englische Bücher, Cambridge University Press

Nouveaux livres Thalia.de
No. 17396405 Frais d'envoi, Versandfertig in 1 - 2 Wochen, DE (EUR 0.00)
Details...
(*) Livre non disponible signifie que le livre est actuellement pas disponible à l'une des plates-formes associées nous recherche.
Progress in Neurotherapeutics and Neuropsychopharmacology: Volume 3, 2008 - Jeffrey L. Cummings
Livre non disponible
(*)
Jeffrey L. Cummings:
Progress in Neurotherapeutics and Neuropsychopharmacology: Volume 3, 2008 - Livres de poche

2009, ISBN: 9780521115612

ID: 10133041

Softcover, Buch, [PU: Cambridge University Press]

Nouveaux livres Lehmanns.de
Frais d'envoiVersand in 15-20 Tagen, , Versandkostenfrei innerhalb der BRD. (EUR 0.00)
Details...
(*) Livre non disponible signifie que le livre est actuellement pas disponible à l'une des plates-formes associées nous recherche.

Détails sur le livre

Informations détaillées sur le livre - Progress in Neurotherapeutics and Neuropsychopharmacology: Volume 3, 2008


EAN (ISBN-13): 9780521115612
ISBN (ISBN-10): 0521115612
Livre de poche
Date de parution: 2010
Editeur: CAMBRIDGE UNIV PR
297 Pages
Poids: 0,499 kg
Langue: eng/Englisch

Livre dans la base de données depuis 13.03.2009 00:15:01
Livre trouvé récemment le 23.06.2018 11:46:30
ISBN/EAN: 9780521115612

ISBN - Autres types d'écriture:
0-521-11561-2, 978-0-521-11561-2


< pour archiver...
Livres en relation